151 related articles for article (PubMed ID: 10030273)
1. Computerized design of target margins for treatment uncertainties in conformal radiotherapy.
Mageras GS; Fuks Z; Leibel SA; Ling CC; Zelefsky MJ; Kooy HM; van Herk M; Kutcher GJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):437-45. PubMed ID: 10030273
[TBL] [Abstract][Full Text] [Related]
2. A study of the effects of internal organ motion on dose escalation in conformal prostate treatments.
Happersett L; Mageras GS; Zelefsky MJ; Burman CM; Leibel SA; Chui C; Fuks Z; Bull S; Ling CC; Kutcher GJ
Radiother Oncol; 2003 Mar; 66(3):263-70. PubMed ID: 12742265
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.
De Meerleer GO; Vakaet LA; De Gersem WR; De Wagter C; De Naeyer B; De Neve W
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):639-48. PubMed ID: 10837946
[TBL] [Abstract][Full Text] [Related]
4. The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field.
Milecki P; Piotrowski T; Dymnicka M
Neoplasma; 2004; 51(1):64-9. PubMed ID: 15004663
[TBL] [Abstract][Full Text] [Related]
5. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
Jiang R; Barnett RB; Chow JC; Chen JZ
Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
[TBL] [Abstract][Full Text] [Related]
6. A numerical simulation of organ motion and daily setup uncertainties: implications for radiation therapy.
Killoran JH; Kooy HM; Gladstone DJ; Welte FJ; Beard CJ
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):213-21. PubMed ID: 9054898
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of treatment optimization directly incorporating random patient setup uncertainty with a margin-based approach.
Moore JA; Gordon JJ; Anscher MS; Siebers JV
Med Phys; 2009 Sep; 36(9):3880-90. PubMed ID: 19810460
[TBL] [Abstract][Full Text] [Related]
8. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of dosimetric margins in prostate IMRT treatment plans.
Gordon JJ; Siebers JV
Med Phys; 2008 Feb; 35(2):569-75. PubMed ID: 18383678
[TBL] [Abstract][Full Text] [Related]
10. Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria.
Gordon JJ; Sayah N; Weiss E; Siebers JV
Med Phys; 2010 Feb; 37(2):550-63. PubMed ID: 20229863
[TBL] [Abstract][Full Text] [Related]
11. Class solutions for conformal external beam prostate radiotherapy.
Khoo VS; Bedford JL; Webb S; Dearnaley DP
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1109-20. PubMed ID: 12605991
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
Kassim I; Dirkx ML; Heijmen BJ
Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
[TBL] [Abstract][Full Text] [Related]
13. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
[TBL] [Abstract][Full Text] [Related]
14. The influence of interpatient and intrapatient rectum variation on external beam treatment of prostate cancer.
Yan D; Xu B; Lockman D; Kota K; Brabbins DS; Wong J; Martinez AA
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1111-9. PubMed ID: 11704336
[TBL] [Abstract][Full Text] [Related]
15. Coverage-based treatment planning to accommodate delineation uncertainties in prostate cancer treatment.
Xu H; Gordon JJ; Siebers JV
Med Phys; 2015 Sep; 42(9):5435-43. PubMed ID: 26328992
[TBL] [Abstract][Full Text] [Related]
16. A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans.
Mageras GS; Kutcher GJ; Leibel SA; Zelefsky MJ; Melian E; Mohan R; Fuks Z
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):333-42. PubMed ID: 8635941
[TBL] [Abstract][Full Text] [Related]
17. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy.
Zelefsky MJ; Crean D; Mageras GS; Lyass O; Happersett L; Ling CC; Leibel SA; Fuks Z; Bull S; Kooy HM; van Herk M; Kutcher GJ
Radiother Oncol; 1999 Feb; 50(2):225-34. PubMed ID: 10368047
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
[TBL] [Abstract][Full Text] [Related]
19. Prostate target volume variations during a course of radiotherapy.
Antolak JA; Rosen II; Childress CH; Zagars GK; Pollack A
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):661-72. PubMed ID: 9806528
[TBL] [Abstract][Full Text] [Related]
20. The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer.
Siedschlag C; Boersma L; van Loon J; Rossi M; van Baardwijk A; Gilhuijs K; Stroom J
Radiother Oncol; 2011 Sep; 100(3):344-50. PubMed ID: 21955665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
